Join the 'Acute Coronary Syndrome -- Prophylaxis' group to help and get support from people like you. How it works
Acute Coronary Syndrome -- Prophylaxis Blog
| Tweet |
Newer Blood Thinner Beats Plavix for Bypass Patients
Posted 16 Mar 2010 by Drugs.com
TUESDAY, March 16 – In a trial comparing two anti-clotting drugs, patients given Brilinta before cardiac bypass surgery were less likely to die than those given Plavix, researchers found. Both drugs prevent platelets from clumping and forming clots, but Plavix, the more popular drug, has been linked to potentially dangerous side effects in cancer patients. In addition, some people don't metabolize it well, making it less effective. "We did see about a 50 percent reduction in mortality in these patients [who took Brilinta], but without any increase in bleeding complications," Dr. Claes Held, an associate professor of cardiology at the Uppsala Clinical Research Center at Uppsala University in Sweden and the study's lead researcher, said during an afternoon press conference Tuesday. "Ticagrelor (Brilinta) in this setting, with acute coronary syndrome patients with the potential need for ... Read more
Related support groups: Plavix, Platelet Aggregation Inhibition, Acute Coronary Syndrome, Acute Coronary Syndrome -- Prophylaxis